LRRK2 and Parkinson disease: Given the concerns of experimentation in non-human primates with respect to research cost, duration and limited number of subjects, LRRK2 mouse models remain an invaluable, initial in vivo experimental platform for understanding disease pathogenesis and for evaluation of novel therapeutics in terms of bioavailability, safety and on-target tissue specificity to PD.